These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30654486)

  • 21. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Executive Function in Everyday Life-Psychometric Properties of the Norwegian Adaptation of the Children's Cooking Task.
    Finnanger TG; Andersson S; Chevignard M; Johansen GO; Brandt AE; Hypher RE; Risnes K; Rø TB; Stubberud J
    Front Hum Neurosci; 2021; 15():761755. PubMed ID: 35185492
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurodevelopment and early pharmacological interventions in Fragile X Syndrome.
    Milla LA; Corral L; Rivera J; Zuñiga N; Pino G; Nunez-Parra A; Cea-Del Rio CA
    Front Neurosci; 2023; 17():1213410. PubMed ID: 37599992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of ultrasonic vocalizations of Fragile X mice.
    Belagodu AP; Johnson AM; Galvez R
    Behav Brain Res; 2016 Sep; 310():76-83. PubMed ID: 27142239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic variability to medication management: an update on fragile X syndrome.
    Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
    Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and behavioral correlates of caudate subregion shape variation in fragile X syndrome.
    Peng DX; Kelley RG; Quintin EM; Raman M; Thompson PM; Reiss AL
    Hum Brain Mapp; 2014 Jun; 35(6):2861-8. PubMed ID: 24038999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of executive functioning challenges and strengths in autistic adults.
    St John T; Woods S; Bode T; Ritter C; Estes A
    Clin Neuropsychol; 2022 Jul; 36(5):1116-1147. PubMed ID: 34499568
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of Executive Functions in Preschool Children With Sickle Cell Anemia.
    Downes M; Kirkham FJ; Telfer PT; de Haan M
    J Int Neuropsychol Soc; 2018 Oct; 24(9):949-954. PubMed ID: 29843828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Event-related potential alterations in fragile X syndrome.
    Knoth IS; Lippé S
    Front Hum Neurosci; 2012; 6():264. PubMed ID: 23015788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identity and Reproductive Aspects in Females with Fragile X Syndrome.
    Reiss S; Zalles L; Gbekie C; Lozano R
    Womens Health Rep (New Rochelle); 2021; 2(1):500-506. PubMed ID: 34841396
    [No Abstract]   [Full Text] [Related]  

  • 31. Cognition, academic achievement, and adaptive behavior in school-aged girls with fragile X syndrome.
    Jordan TL; Bartholomay KL; Lee CH; Lightbody AA; Reiss AL
    Res Dev Disabil; 2023 Dec; 143():104622. PubMed ID: 37939495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability.
    Wilkinson CL; Nelson CA
    Mol Autism; 2021 Feb; 12(1):17. PubMed ID: 33632320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced Excitatory Connectivity and Disturbed Sound Processing in the Auditory Brainstem of Fragile X Mice.
    Garcia-Pino E; Gessele N; Koch U
    J Neurosci; 2017 Aug; 37(31):7403-7419. PubMed ID: 28674175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragile X syndrome: a review of clinical and molecular diagnoses.
    Ciaccio C; Fontana L; Milani D; Tabano S; Miozzo M; Esposito S
    Ital J Pediatr; 2017 Apr; 43(1):39. PubMed ID: 28420439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of stimulus salience on touchscreen serial reversal learning in a mouse model of fragile X syndrome.
    Dickson PE; Corkill B; McKimm E; Miller MM; Calton MA; Goldowitz D; Blaha CD; Mittleman G
    Behav Brain Res; 2013 Sep; 252():126-35. PubMed ID: 23747611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
    Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
    Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS).
    Knox A; Schneider A; Abucayan F; Hervey C; Tran C; Hessl D; Berry-Kravis E
    J Neurodev Disord; 2012 Feb; 4(1):2. PubMed ID: 22958782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing our understanding of human cognition through the study of Fragile X Syndrome.
    Cook D; Nuro E; Murai KK
    Dev Neurobiol; 2014 Feb; 74(2):147-77. PubMed ID: 23723176
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.